Insomnia News: Breaking Insomnia News, Comments and Articles. - Page: 4

United Spinal Co-Hosts Disabilities Conference

NEW YORK -- United Spinal Association, Independence Care System (ICS), and the National MS Society will co-host the fourth annual 'From Within' Women's Health Conference to improve the lives, health, and well-being of women living with spinal cord injuries and disorders. The event will take place Saturday, June 1 from 9:30 am-4:30 p.m. at Hunter-Bellevue School of Nursing, 425 East 25th St. in...

Sleep Quality And School Performance Impaired By Asthma Symptoms

The negative effects of poorly controlled asthma symptoms on sleep quality and academic performance in urban schoolchildren has been confirmed in a new study...

Addressing Mental Health Issues In HIV Care

The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's PLOS Medicine. Syvia Kaaya...

At-risk women 'underestimate likelihood of fractures'

Postmenopausal women with conditions such as Parkinson's disease and multiple sclerosis (MS) tend to underestimate their risk of fractures, a study suggests.The bone-thinning disease osteoporosis mainly affects women following the menopause, greatly increasing their chances of fracturing a bone.Women with some neurological conditions, rheumatoid arthritis or a history of stroke are at least tw...

Suvorexant’s “Twilight Zone”: Advisory Panel, FDA Favor Low Dose; Merck Does Not

FDA and its advisors seem to support lowering the proposed dose for Merck insomnia treatment suvorexant as a way to save the marketing application, but Merck appears insistent that the lower 10 mg dose doesn’t work.

Sleep Apnea Symptoms In Childhood Treated By Early Removal Of Adenoids And Tonsils

Adenotonsillectomy, or the removal of the adenoids and tonsils, is performed 500,000 times a year in the United States, often as a treatment for children with obstructive sleep apnea. However, the procedure's ability to improve a child's attention an...

The secret lives, and deaths, of neurons

(University of North Carolina Health Care) University of North Carolina School of Medicine researchers uncover surprising insights about how nerve cells rewire themselves, shedding light on a process linked with neurodegenerative diseases and neurode...

Partech, Kennedy Krieger Institute collaborate to develop software to identify ASD

Partek Incorporated has partnered with Kennedy Krieger Institute to develop commercial software, which will aid in analyzing genomic data from patients suffering with autism spectrum disorder and mental health disorders.

FDA panel says Merck's sleep drug safe, effective at lower dose

WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug was safe and effective at the lower of two doses studied, a panel of medical experts said on Wednesday, increasing the chance it will be approved by the U.S. Food and Drug Administration....

UPDATE 1-FDA panel says Merck's sleep drug safe, effective at lower dose

WASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug was safe and effective at the lower of two doses studied, a panel of medical experts said on Wednesday, increasing the chance it will be approved by the U.S. Food and Drug Adminis...

Merck Statement on FDA Advisory Committee Meeting for Suvorexant

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S. Food and Drug Administration (FDA) about suvorexant, Merck’s investigational medicine to treat insomnia. “We are excited abou...

Alopecia Areata Associated With Autoimmune Comorbidity

Alopecia areata appears to be associated with autoimmune disorders, atopic dermatitis, and psychiatric disorders. Medscape Medical News

FDA panel: Merck's insomnia drug effective, safe at low doses

WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts said on Wednesday.

Neurodevelopmental disorders among individuals with duplication of 4p13 to 4p12 containing a GABAA receptor subunit gene cluster

Biochemical screening and PTEN mutation analysis in individuals with autism spectrum disorders and macrocephaly

Neurodegeneration: Amyloid awakenings

Sleep disturbances may be an early sign of neurodegenerative diseases — but could sleep deficits cause these conditions in the first place?

Insomnia: Chasing the dream

A combination of drugs and cognitive behavioural therapy may finally put an end to the misery of sleepless nights.

Mood disorders: The dark night

The causal relationships between lack of sleep and mood disorders remain murky. But one thing is clear as day: better sleep can have psychological benefits.

Perspective: Casting light on sleep deficiency

The use of electric lights at night is disrupting the sleep of more and more people, says Charles Czeisler.

Obesity: Heavy sleepers

A growing body of evidence shows that getting a good night's sleep plays an important role in regulating the body's metabolism.

Sleep

Structure: The anatomy of sleep

Neuroscience: Off to night school

One of sleep's most important functions is processing memory. Researchers are now starting to figure out how the brain helps us learn when we're asleep.

Deprivation: A wake-up call

Studies that restrict sleep show why a lack of shut-eye can lead to serious chronic disease.

New insomnia drug is effective, FDA finds

By Matthew PerroneAssociated PressA federal panel of medical experts said that an experimental insomnia drug from Merck & Co. Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving. A maj …